NeuralNET Cerebral Palsy Pilot Study
Key facts
- Who runs it
- University of Cambridge
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 66 people, planned
- Started
- 14 Apr 2023
- Ended
- 31 Jan 2026
- Type of study
- Observational
- Treatments tested
- Whole-genome sequencing
- Record updated
- 30 March 2025
Who can take part
- Age
- Up to 15 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Children with cerebral palsy (CP):
- Has a clinical diagnosis of CP in the medical record
- Any GMFCS score (GMFCS 1-5)
- Does not have a known genetic diagnosis that explains the CP phenotype
- Has a parent/legal guardian available who can consent and is willing to complete study questionnaires
- Invited to participate by a clinician at a participating recruitment site; Biological parents of children with CP will also be included in the study if they are:
- A biological parent of the child
- Aged 18 years or above
- Willing and able to give informed consent for participation in the study Participant type
Who cannot take part
- Aged 18 years or above
- Children with cerebral palsy (CP):
- Children that have a pre-existing genetic diagnosis from whole genome sequencing or whole-exome sequencing
- Children not matching the inclusion criteria; Biological parents of children with CP will be excluded from the study if they do not meet the biological parent inclusion criteria i.e. they ARE NOT:
- A biological parent of the child
- Willing and able to give informed consent for participation in the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The NeuralNET Cerebral Palsy Pilot Study is testing a genetic testing pathway in the NHS for children with cerebral palsy (CP). Other studies suggest that almost one in three peoples' CP is caused by a change in their genes, but more studies are needed to confirm this. A genetic test called whole genome sequencing (WGS) will be used for children who have CP to look for rare changes in genes that cause the condition, and the results of the test will be given to children's doctors within 12 weeks. Knowing that CP has a genetic cause could lead to changes being made to a child's care or treatment that could improve their condition.
Read full original descriptionShow less
The study will test 66 children with CP from 3 hospitals, and also their biological parent(s), if they're available. Following informed consent, the investigators will collect a blood sample from everyone taking part which will be sent for WGS. It is important to understand what families think and feel about the testing. The investigators will ask parents/guardians of the children taking part to fill in two questionnaires, one before and one after WGS. Some parents/guardians will also be interviewed after getting the WGS result, to ask about their experience of the testing. The study will take up to 16 months per family.
The results of this pilot study will tell the investigators if it is feasible for the NHS to use WGS to test children with CP. If so, a larger study testing more children with CP can then be carried out to help decide if this type of WGS-based testing should be made available through the NHS to children with CP whose clinical care might be changed by the result. The genetic findings from this study will also be made available to other researchers and doctors to do more research into CP that might help improve general understanding of the condition and its potential treatment.
Treatments tested
- Whole-genome sequencing
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The NeuralNET: Research to Impact Diagnosis, Mechanistic Understanding and Treatment of Children's Brain and Mental Health Disorders - A Pilot Study in Cerebral Palsy
- Record updated
- 30 March 2025